Moody Aldrich Partners »

Nektar Therapeutics shares owned by Moody Aldrich Partners

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Moody Aldrich Partners from 13F filings

Historical chart of Moody Aldrich Partners investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Moody Aldrich Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Moody Aldrich Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.2M 74k 56.90
2025-06-30 $1.2M 45k 25.84

More positions owned by Moody Aldrich Partners

Cadence Bank (CADE)
Independent Bank (INDB)
Protagonist Therapeutics (PTGX)
Kratos Defense & Sec Solutio Com New (KTOS)
Piper Jaffray Companies (PIPR)
Meta Financial (CASH)
Modine Manufacturing (MOD)
Element Solutions (ESI)
Merus N V (MRUS)
Core Scientific (CORZ)
Riot Blockchain (RIOT)
Columbia Banking System (COLB)
Scorpio Tankers SHS (STNG)
Cargurus Com Cl A (CARG)
VSE Corporation (VSEC)

View all positions for Moody Aldrich Partners

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics